196 related articles for article (PubMed ID: 21749293)
1. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
[TBL] [Abstract][Full Text] [Related]
2. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
3. Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy.
Kang SH; Cho HJ; Shim G; Lee S; Kim SH; Choi HG; Kim CW; Oh YK
Pharm Res; 2011 Dec; 28(12):3069-78. PubMed ID: 21879387
[TBL] [Abstract][Full Text] [Related]
4. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
Mykhaylyk O; Sanchez-Antequera Y; Vlaskou D; Cerda MB; Bokharaei M; Hammerschmid E; Anton M; Plank C
Methods Mol Biol; 2015; 1218():53-106. PubMed ID: 25319646
[TBL] [Abstract][Full Text] [Related]
5. Efficient and gentle siRNA delivery by magnetofection.
Ensenauer R; Hartl D; Vockley J; Roscher AA; Fuchs U
Biotech Histochem; 2011 Aug; 86(4):226-31. PubMed ID: 20297946
[TBL] [Abstract][Full Text] [Related]
6. Liposomal magnetofection.
Mykhaylyk O; Sánchez-Antequera Y; Vlaskou D; Hammerschmid E; Anton M; Zelphati O; Plank C
Methods Mol Biol; 2010; 605():487-525. PubMed ID: 20072903
[TBL] [Abstract][Full Text] [Related]
7. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
Mikhaylova M; Stasinopoulos I; Kato Y; Artemov D; Bhujwalla ZM
Cancer Gene Ther; 2009 Mar; 16(3):217-26. PubMed ID: 18927599
[TBL] [Abstract][Full Text] [Related]
8. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.
Khatri N; Baradia D; Vhora I; Rathi M; Misra A
AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330
[TBL] [Abstract][Full Text] [Related]
11. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA.
Yu YH; Kim E; Park DE; Shim G; Lee S; Kim YB; Kim CW; Oh YK
Eur J Pharm Biopharm; 2012 Feb; 80(2):268-73. PubMed ID: 22108492
[TBL] [Abstract][Full Text] [Related]
12. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
Kapoor M; Burgess DJ
Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
[TBL] [Abstract][Full Text] [Related]
13. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in magnetofection and its potential to deliver siRNAs in vitro.
Mykhaylyk O; Zelphati O; Hammerschmid E; Anton M; Rosenecker J; Plank C
Methods Mol Biol; 2009; 487():111-46. PubMed ID: 19301645
[TBL] [Abstract][Full Text] [Related]
15. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
[TBL] [Abstract][Full Text] [Related]
16. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
17. siRNA delivery by magnetofection.
Mykhaylyk O; Zelphati O; Rosenecker J; Plank C
Curr Opin Mol Ther; 2008 Oct; 10(5):493-505. PubMed ID: 18830925
[TBL] [Abstract][Full Text] [Related]
18. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
Han SE; Kang H; Shim GY; Suh MS; Kim SJ; Kim JS; Oh YK
Int J Pharm; 2008 Apr; 353(1-2):260-9. PubMed ID: 18178348
[TBL] [Abstract][Full Text] [Related]
19. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
20. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action.
Dzmitruk V; Szulc A; Shcharbin D; Janaszewska A; Shcharbina N; Lazniewska J; Novopashina D; Buyanova M; Ionov M; Klajnert-Maculewicz B; Gómez-Ramirez R; Mignani S; Majoral JP; Muñoz-Fernández MA; Bryszewska M
Int J Pharm; 2015 May; 485(1-2):288-94. PubMed ID: 25796120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
